WT1 peptide vaccination treatment for leukaemia: a phase I/II safety and toxicity study (WTPV-001)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 08 Sep 2006
At a glance
- Drugs INNO 305 (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms WTPV
- 08 Sep 2006 The expected completion date for this trial is now 1 May 2007.
- 08 Sep 2006 Status change
- 08 Sep 2006 New trial record.